CryoLife to Distribute Medafor Hemostatic Agent

CryoLife, in a three-year agreement signed last week, will become the exclusive U.S. distributor of Minneapolis, MN-based Medafor’s microporous polysaccharide hemostatic (MPH) agent for use in cardiac and vascular surgeries. CryoLife will also offer MPH outside of the U.S. (excluding Japan and China)...

Boston Scientific to Acquire CryoCor

Boston Scientific will acquire CryoCor for $17.6 million in cash or $1.35 per share. The buyout comes after a tumultuous year for the San Diego-based company; CryoCor stock traded as high as $7.20 prior to regulatory difficulties. CryoCor suffered a blow in June when it learned that FDA was unhappy with its...

Cancer Researchers See the Light: Caliper Life Sciences Intruduces Bioware Ultra

Five cancer cells were injected subcutaneously into the dorsal region near the thigh of mouse. Tumor growth is monitored weekly by an IVIS Spectrum. The tumor was visible 28 days post implantation; Bioluminescent signal could be detected in the animal long before it could be measured with a caliper. By...

Natus Further Consolidates U.S. Newborn Hearing Loss Screening Market with SonaMed Acquisition

Natus Medical announced yesterday that it will acquire SonaMed, a privately held company based in Waltham, MA. SonaMed manufactures and markets the Clarity Screener for the screening of hearing loss in newborns. The company reported revenues of $3.5 million in 2007. According to Jim Hawkins, Natus’...

InSound Medical’s Lyric: A Long Time Coming

The New York Times offered high praise today to hearing aid developed by Newark, CA-based InSound Medical. The device, Lyric, is placed completely within the ear canal by a physician during a three-minute, non-surgical procedure requiring no anesthesia. Lyric was cleared by the FDA in 2002 (it was then...

AngioDynamics Offers to Purchase Diomed Assets

AngioDynamics and Diomed, who once sat on opposing sides of the courtroom, have found occasion to work together, though only after Diomed filed for bankruptcy. Angiodynamics has agreed to pay $8 million in cash for Diomed’s U.S. business engaged in the sale of endovenous laser systems for the...

AdvaMed 2008 Now Accepting Applications for Company Presentations

Medical technology and device companies interested in raising capital, partnering products or initiating strategic alliances are encouraged to apply for a presentation slot at AdvaMed 2008. The application deadline is June 20th, 2008. Open to companies at all stages of development, presentation applications...

Vascular Solutions Settles with Diomed for $3.5 Million

Diomed has fought literally to the death in defense of its “777 Patent” covering the endovascular laser treatment of varicose veins. In March, the company filed for bankruptcy, smothered by legal issues which turned the device manufacturer into little more than a law firm. Diomed will sell some of its...